Navigation Links
Nile Therapeutics Reports 2010 Fourth Quarter and Full Year Financial Results
Date:3/14/2011

SAN FRANCISCO, March 14, 2011 /PRNewswire/ -- Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced its fourth quarter and full year financial results for 2010.  The company will host a conference call and live webcast to discuss these financial results and provide an update on each of its development programs at 4:30 p.m. EDT on March 15, 2011. Interested investors may participate in the conference call by dialing +1-877-303-1595 (USA) or +1-970-315-0449 (international).  Participants may also access both the live and archived webcast of the conference call from the homepage and the investor relations section of Nile's website at www.nilethera.com.  

Financial ResultsFor the fourth quarter of 2010, Nile reported a net operating loss of $0.8 million, or $0.02 per share. For the full year, net operating loss was $6.0 million, or $0.19 per share. Weighted-average shares outstanding for the quarter and the year ended December 31, 2010 were 34.6 million and 32.2 million, respectively. Nile reported no revenue during the quarter and the year ended December 31, 2010.

As of December 31, 2010, Nile had cash and cash equivalents of $3.4 million compared to $3.2 million as of December 31, 2009. Cash used in operations during the year ended December 31, 2010 was $4.3 million.  Nile raised $4.5 million in 2010 through a public offering of common stock and warrants and through the exercise of stock options and warrants.

Update on cenderitide programIn 2010, Nile completed a Phase 2 study of cenderitide (formerly CD-NP), its lead product candidate, in 77 patients with acute decompensated heart failure (ADHF) and mild to moderate renal insufficiency. Data will be presented at the American College of Cardiology Sci
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/22/2015)... 22, 2015  ViewRay™, a privately held medical device company, ... distributor agreement with ITOCHU Corporation (Tokyo Stock Exchange TYO: ... the treatment of cancer in Japan ... world,s first and only MRI-guided radiation therapy system that ...
(Date:1/22/2015)... Jan. 22, 2015  Amgen (NASDAQ: AMGN ) today announced ... financial results on Tuesday, Jan. 27, 2015, after the close of ... conference call with the investment community at 2 p.m. PT. Participating ... , chairman and chief executive officer, and other members of Amgen,s ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Liberty University has ... (M.A.) program from the Council for Accreditation of ... part of Liberty’s Center for Counseling & Family Studies ... dean of the university’s new School of Behavioral Sciences. Prior ...
(Date:1/22/2015)... 2015 Gabe’s Chemo Duck Program is pleased to ... app ever created for kids with cancer. The Chemo Duck App, ... is filled with enjoyable games to help children of all ages ... app helps to keep kids entertained, educated and at ease while ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 Angelweddingdress is a ... business invites its customers to follow it on Facebook, Twitter, ... a Valentine’s Day gift. Angelweddingdress draws a lottery every week. ... Sale to Feb. 28, 2015. Click Angelweddingdress homepage ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2
... By Steven Reinberg HealthDay Reporter , ... full-body scanners increasingly used to screen U.S. airline passengers ... researchers report. Health concerns have arisen since the ... a counter-terrorism tactic. The TSA now operates 486 scanners ...
... Amanda Gardner HealthDay Reporter , MONDAY, March 28 ... traditional exposure therapy may help anxious patients overcome their fear ... exposing people to the thing they fear -- be it ... But while promising, this experimental treatment is not ...
... (March 28, 2011) -- Bariatric surgery should be considered ... stem the serious complications that can result from diabetes, ... presented by leading experts at the 2nd World Congress ... York. The statement was written by 20 leading ...
... through and also affect the distribution carbon-dioxide-absorbing phytoplankton in the ... San Diego and the University of San Diego. ... phytoplankton in the Atlantic sector of the Southern Ocean and ... the Antarctic Peninsula. Enhanced phytoplankton growth would increase the ...
... (HealthDay News) -- Seeing other people scratching can cause ... The team at Wake Forest Baptist Medical Center ... "It is conceivable that the neuronal networks or ... ones involved in contagious yawning, a phenomenon that is ...
... findings on the differences in heart disease among women ... characteristics such as gender and ethnicity matter when it ... Bisexual, and Transgender People: Building a Foundation for Understanding, ... steps to ensure that clinical researchers identify and address ...
Cached Medicine News:Health News:Airport Scanners Appear Safe, Study Finds 2Health News:Airport Scanners Appear Safe, Study Finds 3Health News:Airport Scanners Appear Safe, Study Finds 4Health News:Stress Hormone Might Help Overcome Fear of Heights 2Health News:International Diabetes Federation supports surgery to treat diabetes 2Health News:International Diabetes Federation supports surgery to treat diabetes 3Health News:Icebergs in the Antarctic play important role in carbon cycle 2Health News:Seeing Others Scratch Can Trigger Your Own Itch 2
The Prism Exophthalmometer provides precise measurement of patient's exophthalmos....
The first daily disposable lens affordable enough for full time wear....
... Magellan Mapper connects via a ... or desktop computer featuring Windows ... state of the art corneal ... bright ring projection and easy ...
... CT System combines sophisticated analysis and ... user-friendly platform. The ATLAS is ideal ... pathology detection and corneal refractive surgery ... comes standard with the Advanced Refractive ...
Medicine Products: